NCT04767308 2021-02-23
Safety and Efficacy of CT125A Cells for Treatment of Relapsed/Refractory CD5+ Hematopoietic Malignancies
Huazhong University of Science and Technology
Phase EARLY_PHASE1 Unknown
Huazhong University of Science and Technology
Guilin Medical University, China
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Sun Yat-sen University
Fudan University